sandipkumar38491

Transradial Access Devices Market Trends, Size and Share Analysis By Product (Catheters, Guidewires), Application (Drug Administration, Blood Transfusion), Disease Area (Cardiovascular Diseases, Cancer, Stroke), End-User (Hospitals, Clinics) – Global Forecast Till 2023

The European transradial access devices market analysis shows surging cases of obesity along with the increasing number of chemotherapy procedures and growing use of radial access devices in pediatric patients. The wide scope of application for transradial access devices is a factor that is expected to be responsible for the rapid growth of the market.

The global transradial access devices market consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas dominated the global transradial access devices market owing to the use of transradial access devices for detection of cardiovascular diseases along with the demand for early diagnosis. For instance, a study conducted by the Centers for Disease Control and Prevention (CDC) reported that in 2017, 2.7 to 6.1 million people in the United States have (atrial fibrillation) AFib, leading to more than 750,000 hospitalizations each year in the U.S.

The German market is expected to dominate the global transradial access devices market owing to the increase in the prevalence of target diseases coupled with the increasing number of research studies on vascular access devices in Germany.

The implementation of various healthcare reforms such as the Patient Protection and Affordable Care Act (PPACA) and high burden of Cardiovascular Diseases (CVDS) in India coupled with the increasing investments in the Asia Pacific region are the factors favoring the growth of transradial access devices in the Asia Pacific region

The Middle East and Africa is projected to show steady growth in this market due to the strengthening of the healthcare infrastructure in the Middle East and rising prevalence of cancer in Africa along with the subsequent rise in the number of chronic diseases such as cardiovascular diseases, cancer, rheumatoid arthritis, and inflammatory bowel disease.

Transradial Access Devices Market Segmentation

The global transradial access devices market is segmented by product, application, disease area, and end-user.

Based on product, the global transradial access devices market is classified as catheters, guidewires, sheaths and sheath introducers, accessories, and others. Catheters are further divided into cardiovascular catheters, specialty catheters, intravenous catheters, urinary catheters, and neurological catheters. Guidewires are further classified as solid guidewire and wrapped guidewire.

Based on application, the global transradial access devices market is classified as drug administration, fluid and nutrition administration, blood transfusion, and diagnostics and testing.

Based on disease area, the global transradial access devices market is classified as cardiovascular diseases, cancer, rheumatoid arthritis, ischemic stroke, endometriosis, and others.

Based on end-user, the global transradial access devices market is classified as hospitals, clinics, ambulatory care centers, and others.

Transradial Access Devices Market Key Players

Some of the key players in the global transradial access devices market are Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic Plc (Ireland), Merit Medical System, Inc. (US), Boston Scientific Corporation (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), OSCOR Inc. (US), and others.

Browse More Related Research Reports at:

Lichen Sclerosus Treatment Market Trends, Size Analysis | Applications, 2023

Antihistamine Drugs Market Size, Application | Growth Analysis, 2023

Image Guided Radiotherapy Market Size, Trends | Share Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Aseptic Sampling Market Growth, Size and Share Analysis By Type (Manual Aseptic Sampling, Automated Aseptic Sampling), by Technique (Off-Line Sampling Technique, Other Technique), by Application (Upstream Process, Other Process), by End-user– Forecast Till 2023

Aseptic Sampling Market Overview

The booming biopharmaceutical industry is a key factor driving the demand for the aseptic sampling market. Market reports connected with the healthcare industry are being offered by Market Research Future which creates reports on other business verticals that defines the present market scenarios.

The aseptic sampling market insights and share is projected to advance with a formidable CAGR of 14.5% in the duration of the forecast period. The escalating usage and implementation of single-use aseptic sampling systems are powering the expansion of the market. Furthermore, the progressing nature of process efficiency and reduction in the risk of product contamination is anticipated to motivate the expansion of the aseptic sampling market in the coming years.

Aseptic Sampling Market Segmental Analysis

The Aseptic Sampling Market segmentation of the comprises of application, type, technique, region, and end-user. The segmentation of the aseptic sampling market has been on the basis of type comprises of automated aseptic sampling and manual aseptic sampling. The aseptic sampling market segmentation by technique comprises of on-line sampling, off-line sampling technique, and at-line sampling. Based on application, the market has been segmented into downstream process and upstream process. Based on end-user, the aseptic sampling market has been segmented into research and development institutes, pharmaceutical and biotechnology companies, and contract research and manufacturing organizations. The regional basis of segmenting the aseptic sampling market comprises of the Asia Pacific, Americas, Europe, Africa, and the Middle East.

Aseptic Sampling Market Detailed Regional Analysis

The regional analysis of the aseptic sampling market includes regions such as the Asia Pacific, Americas, Europe, Africa, and the Middle East. The European region is predicted to rule the aseptic sampling market globally. The market development in this region is accredited to the growing R&D activities and the budding biopharmaceutical sector. Furthermore, the governments in numerous European countries are backing pharmaceutical companies to unveil new biopharmaceutical products. This factor is anticipated to add to the development of the market. The Americas region is projected to be the next principal market in aseptic sampling owing to the stringent government regulations on safety and quality of pharmaceutical products and the incidence of a steady healthcare system.

Furthermore, the growing government spending for the healthcare sector is projected to back the market development in this region. The Asia Pacific region is projected to be the fastest rising market due to the mounting developments in healthcare infrastructure and increasing number of regional expansions by multinational biopharmaceutical companies. The Middle Eastern and African region is projected to be responsible for the least market share in the aseptic sampling market owing to the subdued development, the absence of technical knowledge, and weak medical facilities in emerging economies in this region.

Aseptic Sampling Market Competitive Analysis

Improved accessibility to diverse resources and capabilities is expected to impel the growth of the market in the coming forecast period. The use of effective strategy execution techniques is anticipated to bear positively on the future growth of the market. Furthermore, the vertical integrations and product strategies of the market is increasing the potential for the market players. The players in the market are attempting to create several leaderships that will allow them to secure a more substantial portion of the market. Product differentiation has formed a favorable product differentiation situation that is adding to the market’s progress. The analysis of the market states that it is poised for an increased growth rate in the forthcoming years.

The main competitors in the aseptic sampling market globally are Sartorius Stedim Biotech, Qualitru Sampling Systems, Thermo Fisher Scientific, Danaher Corporation, Flownamics Analytical Instruments, Saint Gobain, GEA Group, Merck KGaA, Keofitt, Gemü Group, W. L. Gore & Associates, Lonza Group, Trace Analytics, and Bürkle GmbH.

Industry Updates:

Feb 2018 CSP Technologies and QualiTru Sampling Systems have created TruDraw, a single-use aseptic sampling system for liquid dairy products. The sampler includes a tamper-evident feature and is a sterilized, sealed container with a sterile needle connected to draw a sample in, shielding against the risk of external adulteration.

Browse More Related Research Reports at:

Central Pontine Myelinolysis Market Research Report- Forecast to 2023 | MRFR

EMEA Beauty Devices Market Size, Trends | Share Analysis, 2021

Aphakia Market Research Report- Forecast to 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Odontogenic Tumor Market Share Analysis, by Tumor Type (Malignant Odontogenic Tumor and Others), by Diagnosis (Computerized Tomography Scan and Others), by Treatment (Surgery and Others), by End-Users (Dental Clinics, Hospitals, and Others)– Forecast Till 2023

Odontogenic Tumor Market Highlights

The global odontogenic tumor market growth share is dominated by many market players. The key players in the market are engaged in new launches and strategic collaborations to hold their market position.  The odontogenic tumor is the abnormal growth of cells in and around the jaws and teeth. Many of these tumors are benign. In usual cases, odontogenic tumors are malignant means they are likely to spread in jaws and teeth.  This tumor can be diagnosed using different techniques such as computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy. 

The increasing incidence of the odontogenic tumor and other dental-related diseases, rising geriatric population, and increasing incidence of children suffering from an odontogenic tumor and dental clinics are anticipated to drive the growth of the market during the forecast period. However, unfavorable reimbursement scenario and lack of awareness among the people regarding odontogenic tumor may hamper the growth of the market during the assessment period.

Odontogenic Tumor Market Regional Analysis

The Americas is expected to dominate the global odontogenic market during the forecast period owing to the increasing prevalence of odontogenic tumor diseases along with the growing geriatric population and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support from the healthcare sector, coupled with increasing research and development.

Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing market during the forecast period owing to technological developments, an increasing number of advanced surgeries in emerging economies, and favorable government initiatives for healthcare facilities. The Middle East and Africa is anticipated to hold the smallest share of the global odontogenic tumor market. The market growth in this region can be attributed to the increasing healthcare expenditure and lack of awareness among the people regarding odontogenic tumor in children.

Odontogenic Tumor Market Segmentation

The global odontogenic tumor market is segmented into types of tumor, diagnosis, treatment, and end-user. Based on types of tumor the odontogenic tumor market is segmented into two segments, namely, malignant odontogenic tumors and benign odontogenic tumors. Malignant odontogenic tumors are further sub-segmented into ameloblastic carcinoma, primary intraosseous carcinoma, NOS sclerosing odontogenic carcinoma, clear cell odontogenic carcinoma, ghost cell odontogenic carcinoma, odontogenic carcinosarcoma, and odontogenic sarcomas. Benign odontogenic tumors are further segmented into epithelial origin, mixed (Epithelial-Mesenchymal) origin, and mesenchymal origin. Epithelial origin is further sub-segmented into ameloblastoma, conventional, squamous odontogenic tumor, calcifying epithelial odontogenic tumor, and adenomatoid odontogenic tumor. 

Mixed (Epithelial-Mesenchymal) origin is further sub-segmented into ameloblastic fibroma, primordial odontogenic tumor, odontoma, and dentinogenic ghost cell tumor. Mesenchymal origin is further sub-segmented into odontogenic fibroma, odontogenic myxoma/myxofibroma, cementoblastoma, and cemento-ossifying fibroma. On the basis of diagnosis, the odontogenic tumor market is further segmented into computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy. Based on treatment, the odontogenic tumor market is further segmented into surgery, radiation therapy, and chemotherapy. Based on end-user, the odontogenic tumor market is further segmented into hospitals, dental clinics, dental laboratories, dental academics, and research institutes.

Odontogenic Tumor Market Key Players

Some of the key players in the global odontogenic tumor market are Midwest dental Inc, Burkhart Dental Supply Co., Inc, Delta Dental Plans Association, Patterson Dental Supply, Inc, DeCare Dental, LLC, Oral Cancer Prevention International, Inc, Zila, Inc, Altima Dental Canada, Inc, OraTec Corporation, Oral health innovation Ltd, Senior Dental Care, LLC, and Amerident Dental Inc.

Browse More Related Research Reports at:

Americas Medical Rubber Balloon Products Market Research Report- Forecast to 2023 | MRFR

Americas Blood Glucose Test Strip Market Forecast to 2020 | MRFR

Americas Respiratory Therapeutic Devices Market– Forecast to 2020 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Positron Emission Tomography Devices (PET) Market Trends, Size and Share Analysis By Product Type (Full Ring and Partial Ring PET Scanners), Applications (Cardiology, Oncology, Neurology, and Others), End User (Hospitals, and Others) – Global Forecast Till 2023

Positron Emission Tomography Devices (PET) Market Highlights

The global positron emission tomography devices (PET) market forecast approximate CAGR of 5.6% by 2023. According to the 2018 data suggested by the Australian Institute of Health and Welfare, around 5,091 new cases of head and neck cancer were diagnosed and around 1,034 number of deaths occurred from head and neck cancer in Australia.

Increasing cases of head and neck cancer is the key factor driving the positron emission tomography devices (PET) market. Various other factors such as increasing cases of cancer, technological advancements, presence of a large target patient population and rising patient awareness regarding the benefits of positron emission tomography scanning are also expected to propel the growth of the market. However, stringent regulatory guidelines, cost associated with PET scan, and shorter half-life of radioisotopes can hamper the market growth over the forecast period.

Positron Emission Tomography Devices (PET) Market Segmentation

The global positron emission tomography devices (PET) market is segmented based on product type, applications, end user and region.

The global market for positron emission tomography devices (PET), by product type is segmented into full ring PET scanners and partial ring PET scanners.

The market, by applications, is segmented into cardiology, neurology, oncology, orthopaedics, urology, gastroenterology, and others

Based on end user, positron emission tomography devices (PET) market is segmented into hospitals, clinics, diagnostic centres, and others.

Positron Emission Tomography Devices (PET) Market Regional Analysis

The Americas dominated the global market for positron emission tomography devices (PET) owing to presence of major market players and increased prevalence of Alzheimer's dementia within the region. As per the data suggested by the Alzheimer's Association, an estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018.

Europe is expected to hold the second largest position in the global positron emission tomography devices (PET) market. The market growth in this region is attributed to the government support and improving healthcare related research & development activities.

Asia Pacific was projected to be the fastest growing region in 2017. Factors such as, growing cases of head and neck cancer, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the global positron emission tomography devices (PET) market due to the low per capita income, especially within the African region.

Positron Emission Tomography Devices (PET) Market Key Players

Some of the key players in the global positron emission tomography devices (PET) market are Agfa Healthcare, Gamma Medica Inc., GE Healthcare, Neusoft Medical Systems, Oncovision, Koninklijke Philips N.V., Positron Corporation, Siemens AG, Segami Corporation, Spectrum Dynamics Ltd., Naviscan, Inc. MedX Holdings Inc., Modus Medical Devices Inc., Radiology Oncology Systems, Inc., Yangzhou Kindsway Biotech Co. Ltd., Toshiba Corporation, Hitachi, Ltd., and others.

Browse More Related Research Reports at:

Asia Pacific Healthcare Archiving and eDiscovery Market Research Report- Forecast to 2023 | MRFR

Hybrid Operating Room Market Size Analysis, Trends | Application, 2023

Blood Glucose Test Strip Packaging Market– Forecast to 2021 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hair Removal Devices Market Highlights

Global Wearable Tracking Devices Market Share, Insights and Growth Analysis by Types (Wrist Wear, Fitness Bands, Footwear), Application (Healthcare, Consumer Electronics), Sales Channel (Online, And Offline), End-User (Sports Person, Patients) – Global Forecast Till 2023

Global Hair Removal Devices Market Growth held a value of USD 915.2 million in 2017 and is projected to grow at a CAGR of 8.80% over the forecast period. Increasing consciousness about appearance, changing beauty standards among individuals, and growing demand for laser hair removal treatment are major factors propelling the growth of the market.

According to the Cosmetic Surgery National Data Bank Statistics, about 1,035,783 hair removal procedures were performed in 2016. Additionally, the availability of advanced hair removal devices through e-commerce portals and retail stores and growing use of such devices at home are anticipated to boost the growth of the global hair removal devices market. On the other hand, the high cost of hair removal devices and requirements of multiple treatments may restrain the hair removal devices market growth over the assessment period.

Hair Removal Devices Market Regional Analysis

Geographically, the Americas is anticipated to dominate the global hair removal devices market owing to the to the presence well-developed healthcare infrastructure and the increasing number of hair removal procedures in the US. Europe is anticipated to hold the second largest market share in the global hair removal devices market. The market growth in this region is attributed to the increasing popularity of hair removal treatments and availability of skilled professionals in the region.

Moreover, Asia-Pacific region is expected to be the fastest growing market for hair removal devices due to the growing disposable income and demand for cost-effective hair removal devices. In addition to this, growing awareness about beauty devices and services in developing countries is also expected to generate growth opportunities in the untapped markets of Asia-Pacific region. The Middle East & Africa region is anticipated to show minor growth opportunities in the hair removal devices market during the forecast period.

Hair Removal Devices Market Segmentation

The global hair removal devices market has been segmented into product and end-user.

Based on products, the market has been segmented into, energy-based devices, laser devices, intense pulse light (IPL) devices, and others. The laser devices segment has been further divided into diode laser, Nd: YAG laser, and alexandrite laser. The laser devices segment is expected to account for the largest share in the global hair removal devices market in 2017. This large share is majorly attributed to the wider acceptance of the devices, and better results as compared to other products.

Based on end-users, the market has been segmented into beauty clinics, dermatology clinics, home use, and others. The beauty clinics segment is expected to account for the largest share in the global hair removal devices market in 2017 as large population of women prefer beauty clinics over dermatology clinics.

Based on the regions, the market for hair removal devices is segmented into, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The hair removal devices market in the Americas region has further been segmented into North America and Latin America, where-in the North American market is further divided into the US and Canada.

European hair removal devices market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The hair removal devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hair removal devices market in the Middle East & Africa has been segmented into regions such as the Middle East and Africa.

Hair Removal Devices Market Key Players

Some of the prominent players in the global hair removal devices market are Syneron Medical Ltd., Sciton, Inc, Alma Lasers, Ltd., Cynosure, Inc., Cutera Inc., Lumenis Ltd, Lutronic Corporation, Lynton Lasers Ltd, Solta Medical Inc., Strata Skin Sciences, Inc.,., and Venus Concept Canada Corp

Browse More Related Research Reports at:

Clinical Intelligence Market Research Report- Forecast to 2023 | MRFR

Labyrinthitis Market Size, Growth Analysis | Industry Trends, 2023

Perfusion Market Research Report- Forecast to 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Eyelashes Enhancing Agents Market Trends Analysis, Application And Growth Insights By Types, (Curling, Lengthening, Volumizing, And Others), Application (Repairing Damaged Eyelashes, Nourishing), Content (Bimatoprost, Lash-Building Serum, Skincare Ingredients) - Global Forecast Till 2023

Market Research Future (MRFR) has published a research report about the Global Eyelashes Enhancing Agents Market that estimates a decent advancement in this market at a 5.83% CAGR (Compound Annual Growth Rate) between 2017 and 2023. In terms of value, the Eyelashes Enhancing Agents Market trends analysis shows growth expected to be worth the US $ 513.44 million by the end of the forecast period.

Eyelash enhancing serum is a unique formula aimed at improving the overall appearance of eyelashes. The major factors contributing to the moderate growth of the global eyelashes enhancing agents market include the increasing prevalence of eye inflammations, growing demand for natural eyelash enhancer agents, and loss of eyelashes due to continuous uptake of come higher medical dosages. However, the side-effects of eyelashes enhancer agents may hurt the growth of the market.

Key Players:

The key players in the global eyelashes enhancing agents market include Allergan PLC (Republic of Ireland), Athena Cosmetics Inc. (USA), Beauty Essentials LLC (USA), Estee Lauder (USA), Grande Cosmetics LLC (USA), Rodan & Fields LLC (USA), and Skin Research Laboratories (USA).

The global eyelashes enhancing agents market has been segmented on the basis of application, content, type, and lastly, region. The application-based segmentation of this market segments the market into repairing damaged eyelashes, nourishing eyelashes, and others. Based on content, the market has been segmented into bimatoprost, enhancer serum, herbal remedy, isopropyl cloprostenate, lash-building serum, skin care ingredients, and others.  The skin care ingredients have been sub-segmented into biotin, panthenol, polypeptides, and others. By type, the market has been segmented into curling, lengthening, volumizing, and others. Curling has been estimated to emerge as the fastest growing segment during the forecast period.

The regional segmentation of the global segments into the Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas segment holds the biggest share in the global market due to the huge development in the region’s cosmetic industry, presence of strong economic conditions, presence of many key market players, and focus by research institutions on research and development (R&D) in order to update the technology for new and advanced eyelashes enhancing agents. Due to advanced technology and the presence of many strong economies, North America is a bigger market than South America. The major country-specific markets in this region are the USA and Canada.

Europe is the second largest market due to the high density of population, changing lifestyle, growing cosmetics industry, increasing demand for eyelashes enhancing agents, and well-developed technology. Due to similar reasons as the Americas, Western Europe is a bigger market than Eastern Europe. In this region, the major country-specific markets are France, Germany, Italy, and the UK, followed by the remaining countries of Western as well as Eastern Europe.

The Asia Pacific region is the fastest growing regional market, and during the forecast period, it is expected to grow at a 6.26% CAGR. The main factor driving the market growth in this region is the presence of a number of developing nations like China and India in this region. In these countries, the growth of the cosmetics industry is aiding the market growth. Other factors contributing to market growth are the increasing prevalence of eye inflammations and the demand for various eyelashes enhancing agents. Other pivotal country-specific markets in this region are Japan and South Korea, followed by the remaining countries of Asia Pacific.

The MEA region holds the lowest market share due to less availability of medical facilities and lack of healthcare facilities. However, countries such as Kuwait and Qatar are focusing more on the healthcare and cosmetic industries. They are also developing medical facilities, which might create a stable market in this region during the forecast period.

Brows More Healthcare Related Research Reports:

Medical Ventilator Market Trends, Share | Size Analysis, 2023

Healthcare Information Governance Solution Market Report 2027 | MRFR

Filters and Particle Monitoring Market Trends, Size | Growth Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +16468459312

Email: sales@marketresearchfuture.com

Calciphylaxis Market Trends, Size and Share Analysis By Diagnosis (Deep Skin Biopsies, Blood Tests and Imaging), Treatment, (Intensive Wound Care, Medication, Therapy, and Clot-Dissolving), End User (Hospitals, Clinics, Medical Research Centers) - Global Forecast till 2023

Market Highlights

The Global Calciphylaxis Market trends is expected to grow at a CAGR of 10.70% during the forecast period 2017-2023. Warfarin is an oral anticoagulant which inhibits the synthesis of vitamin K- dependent clotting factors. Warfarin is most commonly prescribed cardiovascular agent. However, excess use of anticoagulant increases the risk of calciphylaxis in treatment seeking population. According to the national pharmaceutical regulatory agency (2015), cases of calciphylaxis have been reported in patients on warfarin therapy. Although many of the cases reported for pre-existing renal disease.

Also, in May 2016, European Medicine Agency review concluded that there is reasonable possibility between calciphylaxis and use of warfarin. Taste the market data and market information presented through more than 144 market data tables and 34 figures spread over 152 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “calciphylaxis market research report–Global forecast till 2023.”

Several options are available in the treatment of calciphylaxis, which is associated with hypophosphatemia, and secondary hyperparathyroidism with chronic kidney disease.  These include bisphosphonates, newer non-calcium/non-aluminum-containing phosphate binders and case reports of use of cinacalcet. Other treatments for calcific uremic arteriolopathy (CUA) that are not targeted directly at calcium/phosphate homeostasis include HBOT and the sodium thiosulphate.  The healthcare professionals have stated that randomized controlled trials for treatments in CUA are still lacking, which has restrained the growth of the market.

Major Players in the Calciphylaxis Market

Some of the key players in this market are Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical, ConvaTec Inc, Sanifit, and others.

The global calciphylaxis market consists of four regions the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas account for a major share of the market owing to the presence of patient population, well-developed technology, high healthcare expenditure and the presence of the leading players. Moreover, due to the high prevalence of end stage renal diseases (ESRD) on of the major cause of calciphylaxis in U.S. As per The Regents of the University of California, the rate of ESRD is increasing in the U.S. by 5% per year. The American calciphylaxis market is expected to reach USD 1,257 million by 2023 from USD 581.9 million in 2016.

Europe consists of two regions namely Western Europe and Eastern Europe. Western Europe consists of countries namely Germany, the U.K., France, Italy, Spain, and Rest of Western Europe. Increasing prevalence of cardiovascular calcification in ESRD patients is a key driver for the growth of this market in Europe. Moreover, increasing healthcare expenditure, rising research & development activities, awareness among patients about the treatment options supporting the market growth for calciphylaxis.

Asia Pacific consists of Japan, China, India, Australia, Republic of Korea, and rest of Asia Pacific. Increasing incidence of chronic kidney failure across Asia Pacific. Moreover, the growth of this segment is attributed to high population growth, increasing environmental pollution, and urbanization. Increasing incidence of calciphylaxis, improving healthcare infrastructure and rising awareness about the treatment process have spurred the growth of Asia Pacific region.  

On the other hand, the Middle East & Africa owns the minimum market share of the calciphylaxis market due to less development in the healthcare services such as new and advanced diagnosis & treatment methods in healthcare domain.

Segmentation

The global Calciphylaxis Market is segmented on the basis of diagnosis, treatment, and end user. On the basis of the diagnosis, the calciphylaxis market is further segmented into deep skin biopsies, blood tests, imaging, and others. The deep skin biopsies are further segmented into shave biopsy, punch biopsy, and excisional biopsy. The blood tests is further segmented into serum parathormone levels, blood glucose levels, BUN (blood urea nitrogen), calcium levels, and others. Imaging is further segmented into magnetic resonance imaging (MRI), CT scan, ultrasound, and others.

On the basis of the applications, the market is segmented into intensive wound care, medication, therapy, clot-dissolving, and others. Intensive wound care unit is further segmented into debridement, wet dressings, and others. The medication is further segmented into cinacalcet, sodium thiosulfate, steroids, and bisphosphonates. On the basis of end user, it is segmented into hospitals, clinics, medical research centers, academic institutes, and others.

Brows More Healthcare Related Research Reports:

Wearable Tracking Devices Market Trends, Growth | Size Analysis, 2023

Medical Billing Market Size, Trends | Growth Analysis, 2023

Cholesterol Management Devices Market Size, Growth | Share Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 524/528, Amanora Chambers

Magarpatta Road, Hadapsar

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email:  sales@marketresearchfuture.com

Meralgia Paresthetica Market Size, Growth and Share Analysis By Diagnosis (Imaging Techniques, Electromyography, Nerve Conduction Study, Nerve Blockade), Treatment (Medication, Surgery), End User (Hospitals & Clinics, Research Laboratories) - Global Forecast till 2023 

Market Highlights

The global meralgia paresthetica market size is expected to grow at a CAGR of ~7.9 % during the forecast period 2017-2023. According to Obesity Society, in the United States (2014), 28.1% of the total population was obese. Out of them, 33.7% were men and 36.5% were women. The prevalence of obesity for men and women aged 20-39 years was 39.5% and 35.4%, respectively. The obesity prevalence was higher in the South (29.4%) and Midwest (29.5%) and lower in the Northeast (25.3%) and West (25.1%) of Unites States.

During last decade the number of treatment procedures have increased which has influenced the growth of the market positively. Moreover, increasing number of patients suffering from chronic diseases have increased the demand different treatments in the market. The market is expecting a healthy growth during the next decade. Moreover, well developed technology has supported the growth of the market in this region.

Regional Analysis

The Americas dominate the global meralgia paresthetica market owing to the presence of huge patient population with obesity and diabetes, high healthcare spending, and increasing government support for research & development.    

Europe holds the second largest share of the global meralgia paresthetica market as result of increasing focus of various government agencies on the treatment of chronic diseases. Moreover, the growing public awareness about meralgia paresthetica likely to boost the European market.    

Asia Pacific is the fastest growing meralgia paresthetica market across the globe. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecasted period.  

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Segmentation

The global meralgia paresthetica market is segmented on the basis of types, by treatment, and by end user. On the basis of diagnosis it is segmented into imaging techniques, electromyography, nerve conduction study, nerve blockade. Imaging techniques is further segmented into X-ray radiography, magnetic resonance imaging, medical ultrasonography or ultrasound, and others. Based on the treatment, it is segmented into medication, surgery, and others. Medication is further segmented into corticosteroid injections, tricyclic antidepressants, and anti-seizure. Anti-seizure is further segmented into gabapentin (gralise, neurontin), phenytoin (dilantin) or pregabalin (lyrica) and others. On the basis of end user, it is segmented into hospitals & clinics, research laboratories, and others.

Key Players

Some of key the players in the meralgia paresthetica market are LivaNova PLC (U.K), EnteroMedics Inc. (U.S.), ElectroCore Medical LLC (U.S.), Boston Scientific Corporation (U.S.), Cyberonics, Inc. (U.S.), NeuroMetrix, Inc.(U.S.), ImThera Medical (U.S.), and Inspire Medical Systems, Inc.(U.S.) and others.

Brows More Healthcare Related Research Reports:

Artificial Insemination Market Size Analysis, Share | Industry Trends, 2025

Global Suture wire Market Research Report - Forecast to 2023 | MRFR

Neuropsychiatric Disorders and Treatment Market size, Insights | Industry Trends, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com .

Nystagmus Market Share and Application By Type (Infantile, Latent Nystagmus, Noonan Syndrome, Nystagmus Blockage Syndrome) Diagnosis (Ct Scan, Mr Scan, Chromosome Analysis, Ultrasonography) Treatment (Medication, Surgical) End-User – Global Forecast Till 2023

Market Highlights:

The global Nystagmus market size is expected to grow at a CAGR of ~6.2 % during the forecast period 2017-2023. Increasing prevalence of rare diseases, rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, and availability of funds are driving the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology is expected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth during the period, 2017-2023.

According to the Association for Research in Vision and Ophthalmology (2012), the prevalence of Nystagmus was estimated to be 24.0 per 10,000 population across the globe. The study identified the following as the most common forms of Nystagmus; neurologic Nystagmus (6.8 per 10,000 population), Nystagmus associated with low vision such as congenital cataracts (4.2 per 10,000), and Nystagmus associated with retinal diseases such as achromatopsia.

Regional Analysis:

The Americas dominate the global Nystagmus market owing to the presence of a huge patient population with eye problem, high healthcare spending, and increasing government support for research & development.    

Europe holds the second largest share of the global Nystagmus market as result of increasing focus of various government agencies on the treatment of eye diseases. Moreover, the growing public awareness about Nystagmus is likely to boost the European market.  

The Asia Pacific region is expected to be the fastest growing region and is anticipated to compete with the American and European region during the forecasted period 2017-2023. Japan holds the major share of the regional market due to the availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development is projected to drive the market in China and India over the forecasted period.   

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The U.A.E., Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth. 

Segmentation:

The Nystagmus market is segmented on the basis of type, diagnosis, treatment, and end-users.

Based on the type, the market is segmented into infantile, latent nystagmus, noonan syndrome, and nystagmus blockage syndrome.

On the basis of the diagnosis, the market is segmented into CT scan, MR scan, chromosome analysis, ultrasonography, and others.

On the basis of the treatment, the market is segmented into medications, surgical, and others.

On the basis of the end-user, the market is segmented into hospitals & clinics, research centers, specialty eye clinics, and others.

Key Players:

Some of key the players in the global Nystagmus market are Bristol-Myers Squibb Company, NUSAPURE, ALLERGAN, Aerie Pharmaceuticals, Inc., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Bayer AG, Genentech, Inc., Novartis AG , Regeneron Pharmaceuticals, Inc., Shire, and Santen Pharmaceutical Co., Ltd., and others.

Brows More Healthcare Related Research Reports:

Neuromodulation Devices Market Trends, Share | Size Analysis, 2023

Cardiopulmonary Resuscitation Market Trends, Size | Share Analysis, 2023

Cervical Dystonia Market Trends Analysis, Share | Size, Forecast To 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Drug Infusion System Market Size, Growth and Share Analysis by Product Type (Elastomeric Infusion System, Disposable Infusion System), by Application (Oncology/Chemotherapy), Mode of Administration (Intravenous), End-User (Hospitals) - Global Forecast Till 2023

Market Highlights

The increase in the prevalence of chronic diseases such as cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis increasing the drug infusion system market size. Furthermore, adoption of technologically advanced devices and the rising geriatric population are the key factors for the market to grow. However, factors such as the high cost of drug infusion system, shortage of skilled labor and stringent government rules and regulations for product approval are expected to restrict the market growth during the forecast period.

Regional Analysis

The Americas dominated the global market for Drug infusion system in 2017. This can be attributed due to the rising incidence of chronic diseases like cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis within the region provides favorable backgrounds for market growth. According to the American Heart Association (2018), 92.1 million Americans suffer from some form of the cardiovascular disease. Also, the presence of major market players such as Medtronic and Becton, Dickinson and Company within the region influences the market growth.  

Europe (the UK, Belgium, France & Netherlands) is second in the market owing to increasing healthcare expenditure, and rising prevalence of chronic respiratory diseases is expected to influence the market in this region. According to Eurostat in 2014, 382 thousand deaths were due to chronic respiratory diseases in the European Union (EU). Thus, the rise in chronic respiratory diseases favors the growth of the market in this region.

Asia Pacific is expected to observe the fastest growth for the global Drug infusion system market owing to a growing geriatric population in this region. The Asian Development Bank (ADB) projected that in 2050 the geriatric population is expected to reach 923 million. This offers potential growth opportunities in this region.

The Middle East and Africa accounts for least share due to stringent government policies and poor economies.

Segmentation

The global drug infusion system market is segmented on the basis of product type, mode of administration, application, and end-user. The drug infusion system market, by product type, is sub-segmented into Elastomeric infusion system, Disposable infusion system, Syringe infusion system, Peristaltic pump, Multi-channel pump, Patient-controlled analgesia (PCA) pump, Insulin pump and Implantable infusion system. On the basis of Application, the market is categorized into Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, and others. Mode of administration is further sub-segmented into Intravenous, Subcutaneous, Arterial, Epidural and Others. By end-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic centers and others.

Key Players

Some of the key players for the global Drug infusion system market are Medtronic, Arcomed AG, B. Braun Melsungen AG, Baxter, Becton Dickinson and Company, Debiotech S.A., Fresenius SE & Co. KGaA, Halyard Health, Inc, ICU Medical Inc, IRadimed Corporation, Insulet Corporation, Terumo Corporation, Smiths Group plc, Tandem Diabetes care, MOOG INC., and others.

Brows More Healthcare Related Research Reports:

Middle East and Africa Clinical Trial Imaging Market-Forecast to 2022 | MRFR

Saudi Arabia Medical Devices Market Report – Forecast 2023 | MRFR

Artificial Retina Market Trends Analysis, Size | Applications, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Odontogenic Tumor Market, by Tumor Type (Malignant Odontogenic Tumor and Others), by Diagnosis (Computerized Tomography Scan and Others), by Treatment (Surgery and Others), by End-Users (Dental Clinics, Hospitals, and Others)– Forecast Till 2023

Market Highlights

The odontogenic tumor is the abnormal growth of cells in and around the jaws and teeth. Many of these tumors are considered to be benign. In usual cases, odontogenic tumors are malignant means they are likely to spread in jaws and teeth.  This tumor can be diagnosed using different techniques such as computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy. 

The increasing incidence of the odontogenic tumor and other dental-related diseases, rising geriatric population, and increasing incidence of children suffering from an odontogenic tumor and dental clinics are anticipated to drive the growth of the market during the forecast period. However, unfavorable reimbursement scenario and lack of awareness among the people regarding odontogenic tumor may hamper the growth of the market during the assessment period. The global odontogenic tumor market size is dominated by many market players. The key players in the market are engaged in new launches and strategic collaborations to hold their market position.  

Regional Analysis

The market in the Americas is expected to dominate the global odontogenic market during the forecast period owing to the increasing prevalence of odontogenic tumor diseases along with the growing geriatric population and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support from the healthcare sector, coupled with increasing research and development. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing market during the forecast period owing to technological developments, an increasing number of advanced surgeries in emerging economies, and favorable government initiatives for healthcare facilities.

The Middle East and Africa is anticipated to hold the smallest share of the global odontogenic tumor market. The market growth in this region can be attributed to the increasing healthcare expenditure and lack of awareness among the people regarding odontogenic tumor in children.

Segmentation

The global odontogenic tumor market is segmented into types of tumor, diagnosis, treatment, and end-user. Based on types of tumor the odontogenic tumor market is segmented into two segments, namely,  malignant odontogenic tumors and benign odontogenic tumors. Malignant odontogenic tumors are further sub-segmented into ameloblastic carcinoma, primary intraosseous carcinoma, NOS sclerosing odontogenic carcinoma, clear cell odontogenic carcinoma, ghost cell odontogenic carcinoma, odontogenic carcinosarcoma, and odontogenic sarcomas. Benign odontogenic tumors are further segmented into epithelial origin, mixed (Epithelial-Mesenchymal) origin, and mesenchymal origin. Epithelial origin is further sub-segmented into ameloblastoma, conventional, squamous odontogenic tumor, calcifying epithelial odontogenic tumor, and adenomatoid odontogenic tumor. 

Mixed (Epithelial-Mesenchymal) origin is further sub-segmented into ameloblastic fibroma, primordial odontogenic tumor, odontoma, and dentinogenic ghost cell tumor. Mesenchymal origin is further sub-segmented into odontogenic fibroma, odontogenic myxoma/myxofibroma, cementoblastoma, and cemento-ossifying fibroma. On the basis of diagnosis, the odontogenic tumor market is further segmented into computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy. Based on treatment, the odontogenic tumor market is further segmented into surgery, radiation therapy, and chemotherapy. Based on end-user, the odontogenic tumor market is further segmented into hospitals, dental clinics, dental laboratories, dental academics, and research institutes.

Key Players

Some of the key players in the global odontogenic tumor market are Midwest dental Inc, Burkhart Dental Supply Co., Inc, Delta Dental Plans Association, Patterson Dental Supply, Inc, DeCare Dental, LLC, Oral Cancer Prevention International, Inc, Zila, Inc, Altima Dental Canada, Inc, OraTec Corporation, Oral health innovation Ltd, Senior Dental Care, LLC, and Amerident Dental Inc.

Browse More Related Research Reports at:

Hybrid Operating Room Market Size Analysis, Trends | Application, 2023

Blood Glucose Test Strip Packaging Market– Forecast to 2021 | MRFR

Clinical Intelligence Market Research Report- Forecast to 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Positron Emission Tomography Devices (PET) Market Research Report: By Product Type (Full Ring and Partial Ring PET Scanners), Applications (Cardiology, Oncology, Neurology, and Others), End User (Hospitals, and Others) – Global Forecast Till 2023

Market Highlights

The global positron emission tomography devices (PET) market is expected to grow at an approximate CAGR of 5.6% during forecast period, 2018–2023. According to the 2018 data suggested by the Australian Institute of Health and Welfare, around 5,091 new cases of head and neck cancer were diagnosed and around 1,034 number of deaths occurred from head and neck cancer in Australia.

Increasing cases of head and neck cancer is the key factor driving the positron emission tomography devices (PET) market growth. Various other factors such as increasing cases of cancer, technological advancements, presence of a large target patient population and rising patient awareness regarding the benefits of positron emission tomography scanning are also expected to propel the growth of the market. However, stringent regulatory guidelines, cost associated with PET scan, and shorter half-life of radioisotopes can hamper the market growth over the forecast period.

Segmentation

The global positron emission tomography devices (PET) market is segmented based on product type, applications, end user and region.

The global market for positron emission tomography devices (PET), by product type is segmented into full ring PET scanners and partial ring PET scanners.

The market, by applications, is segmented into cardiology, neurology, oncology, orthopaedics, urology, gastroenterology, and others

Based on end user, positron emission tomography devices (PET) market is segmented into hospitals, clinics, diagnostic centres, and others.

Regional Analysis

The Americas dominated the global market for positron emission tomography devices (PET) owing to presence of major market players and increased prevalence of Alzheimer's dementia within the region. As per the data suggested by the Alzheimer's Association, an estimated 5.7 million Americans of all ages are living with Alzheimer's dementia in 2018.

Europe is expected to hold the second largest position in the global positron emission tomography devices (PET) market. The market growth in this region is attributed to the government support and improving healthcare related research & development activities.

Asia Pacific was projected to be the fastest growing region in 2017. Factors such as, growing cases of head and neck cancer, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the global positron emission tomography devices (PET) market due to the low per capita income, especially within the African region.

Key Players

Some of the key players in the global positron emission tomography devices (PET) market are Agfa Healthcare, Gamma Medica Inc., GE Healthcare, Neusoft Medical Systems, Oncovision, Koninklijke Philips N.V., Positron Corporation, Siemens AG, Segami Corporation, Spectrum Dynamics Ltd., Naviscan, Inc. MedX Holdings Inc., Modus Medical Devices Inc., Radiology Oncology Systems, Inc., Yangzhou Kindsway Biotech Co. Ltd., Toshiba Corporation, Hitachi, Ltd., and others.

Browse More Related Research Reports at:

Labyrinthitis Market Size, Growth Analysis | Industry Trends, 2023

Perfusion Market Research Report- Forecast to 2023 | MRFR

Asia Pacific Suture Needles Market Research Report- Forecast to 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hair Removal Devices Market Research Report: by Product (Energy-based Devices, Laser Devices (Diode Laser, Nd: YAG Laser, Alexandrite Laser), Intense Pulse Light (IPL) Devices, Others), By End-user (Beauty Clinics, Others) - Global Forecast Till 2023

Market Highlights

Global Hair Removal Devices Market held a market value of USD 915.2 million in 2017 and is projected to grow at a CAGR of 8.80% over the forecast period. Increasing consciousness about appearance, changing beauty standards among individuals, and growing demand for laser hair removal treatment are major factors propelling the growth of the market.

According to the Cosmetic Surgery National Data Bank Statistics, about 1,035,783 hair removal procedures were performed in 2016. Additionally, the availability of advanced hair removal devices through e-commerce portals and retail stores and growing use of such devices at home are anticipated to boost the growth of the global hair removal devices market. On the other hand, the high cost of hair removal devices and requirements of multiple treatments may restrain the hair removal devices market size over the assessment period.

Regional Analysis

Geographically, the Americas is anticipated to dominate the global hair removal devices market owing to the to the presence well-developed healthcare infrastructure and the increasing number of hair removal procedures in the US. Europe is anticipated to hold the second largest market share in the global hair removal devices market. The market growth in this region is attributed to the increasing popularity of hair removal treatments and availability of skilled professionals in the region.

Moreover, Asia-Pacific region is expected to be the fastest growing market for hair removal devices due to the growing disposable income and demand for cost-effective hair removal devices. In addition to this, growing awareness about beauty devices and services in developing countries is also expected to generate growth opportunities in the untapped markets of Asia-Pacific region. The Middle East & Africa region is anticipated to show minor growth opportunities in the hair removal devices market during the forecast period.

Segmentation

The global hair removal devices market has been segmented into product and end-user.

Based on products, the market has been segmented into, energy-based devices, laser devices, intense pulse light (IPL) devices, and others. The laser devices segment has been further divided into diode laser, Nd: YAG laser, and alexandrite laser. The laser devices segment is expected to account for the largest share in the global hair removal devices market in 2017. This large share is majorly attributed to the wider acceptance of the devices, and better results as compared to other products.

Based on end-users, the market has been segmented into beauty clinics, dermatology clinics, home use, and others. The beauty clinics segment is expected to account for the largest share in the global hair removal devices market in 2017 as large population of women prefer beauty clinics over dermatology clinics.

Based on the regions, the market for hair removal devices is segmented into, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The hair removal devices market in the Americas region has further been segmented into North America and Latin America, where-in the North American market is further divided into the US and Canada.

European hair removal devices market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The hair removal devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hair removal devices market in the Middle East & Africa has been segmented into regions such as the Middle East and Africa.

Key Players

Some of the prominent players in the global hair removal devices market are Syneron Medical Ltd., Sciton, Inc, Alma Lasers, Ltd., Cynosure, Inc., Cutera Inc., Lumenis Ltd, Lutronic Corporation, Lynton Lasers Ltd, Solta Medical Inc., Strata Skin Sciences, Inc.,., and Venus Concept Canada Corp

Browse More Related Research Reports at:

Eyelashes Enhancing Agents Market Size, Growth | Application, 2023

US Medical Sector Contract Electronic Manufacturing Market Research Report- Forecast to 2022 | MRFR

Calciphylaxis Market Research Report Forecast To 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Transradial Access Devices Market Research Report: By Product (Catheters, Guidewires), Application (Drug Administration, Blood Transfusion), Disease Area (Cardiovascular Diseases, Cancer, Stroke), End-User (Hospitals, Clinics) – Global Forecast Till 2023

The global transradial access devices market consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas dominated the global transradial access devices market owing to the use of transradial access devices for detection of cardiovascular diseases along with the demand for early diagnosis. For instance, a study conducted by the Centers for Disease Control and Prevention (CDC) reported that in 2017, 2.7 to 6.1 million people in the United States have (atrial fibrillation) AFib, leading to more than 750,000 hospitalizations each year in the U.S.

The European region is showing global transradial access devices market growth due to surging cases of obesity along with the increasing number of chemotherapy procedures and growing use of radial access devices in pediatric patients. The wide scope of application for transradial access devices is a factor that is expected to be responsible for the rapid growth of the market.

The German market is expected to dominate the global transradial access devices market owing to the increase in the prevalence of target diseases coupled with the increasing number of research studies on vascular access devices in Germany.

The implementation of various healthcare reforms such as the Patient Protection and Affordable Care Act (PPACA) and high burden of Cardiovascular Diseases (CVDS) in India coupled with the increasing investments in the Asia Pacific region are the factors favoring the growth of transradial access devices in the Asia Pacific region

The Middle East and Africa is projected to show steady growth in this market due to the strengthening of the healthcare infrastructure in the Middle East and rising prevalence of cancer in Africa along with the subsequent rise in the number of chronic diseases such as cardiovascular diseases, cancer, rheumatoid arthritis, and inflammatory bowel disease.

Segmentation

The global transradial access devices market is segmented by product, application, disease area, and end-user.

Based on product, the global transradial access devices market is classified as catheters, guidewires, sheaths and sheath introducers, accessories, and others. Catheters are further divided into cardiovascular catheters, specialty catheters, intravenous catheters, urinary catheters, and neurological catheters. Guidewires are further classified as solid guidewire and wrapped guidewire.

Based on application, the global transradial access devices market is classified as drug administration, fluid and nutrition administration, blood transfusion, and diagnostics and testing.

Based on disease area, the global transradial access devices market is classified as cardiovascular diseases, cancer, rheumatoid arthritis, ischemic stroke, endometriosis, and others.

Based on end-user, the global transradial access devices market is classified as hospitals, clinics, ambulatory care centers, and others.

Key Players

Some of the key players in the global transradial access devices market are Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic Plc (Ireland), Merit Medical System, Inc. (US), Boston Scientific Corporation (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), OSCOR Inc. (US), and others.

Browse More Related Research Reports at:

EMEA Beauty Devices Market Size, Trends | Share Analysis, 2021

Aphakia Market Research Report- Forecast to 2023 | MRFR

Americas Medical Rubber Balloon Products Market Research Report- Forecast to 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Aseptic Sampling Market Research Report: By Type (Manual Aseptic Sampling, Automated Aseptic Sampling), by Technique (Off-Line Sampling Technique, Other Technique), by Application (Upstream Process, Other Process), by End-user– Forecast Till 2023

Aseptic Sampling Market – Overview

The booming biopharmaceutical industry is a key factor driving the demand for the aseptic sampling market. Market reports connected with the healthcare industry are being offered by Market Research Future which creates reports on other business verticals that defines the present market scenarios.

The aseptic sampling market trends is projected to advance with a formidable CAGR of 14.5% in the duration of the forecast period. The escalating usage and implementation of single-use aseptic sampling systems are powering the expansion of the market. Furthermore, the progressing nature of process efficiency and reduction in the risk of product contamination is anticipated to motivate the expansion of the aseptic sampling market in the coming years.

Segmental Analysis

The Aseptic Sampling Market segmentation of the comprises of application, type, technique, region, and end-user. The segmentation of the aseptic sampling market has been on the basis of type comprises of automated aseptic sampling and manual aseptic sampling. The aseptic sampling market segmentation by technique comprises of on-line sampling, off-line sampling technique, and at-line sampling. On the basis of application, the market has been segmented into downstream process and upstream process.

Based on end-user, the aseptic sampling market has been segmented into research and development institutes, pharmaceutical and biotechnology companies, and contract research and manufacturing organizations. The regional basis of segmenting the aseptic sampling market comprises of the Asia Pacific, Americas, Europe, Africa, and the Middle East.

Detailed Regional Analysis

The regional analysis of the aseptic sampling market includes regions such as the Asia Pacific, Americas, Europe, Africa, and the Middle East. The European region is predicted to rule the aseptic sampling market globally. The market development in this region is accredited to the growing R&D activities and the budding biopharmaceutical sector. Furthermore, the governments in numerous European countries are backing pharmaceutical companies to unveil new biopharmaceutical products. This factor is anticipated to add to the development of the market. The Americas region is projected to be the next principal market in aseptic sampling owing to the stringent government regulations on safety and quality of pharmaceutical products and the incidence of a steady healthcare system.

Furthermore, the growing government spending for the healthcare sector is projected to back the market development in this region. The Asia Pacific region is projected to be the fastest rising market due to the mounting developments in healthcare infrastructure and increasing number of regional expansions by multinational biopharmaceutical companies. The Middle Eastern and African region is projected to be responsible for the least market share in the aseptic sampling market owing to the subdued development, the absence of technical knowledge, and weak medical facilities in emerging economies in this region.

Competitive Analysis

Improved accessibility to diverse resources and capabilities is expected to impel the growth of the market in the coming forecast period. The use of effective strategy execution techniques is anticipated to bear positively on the future growth of the market. Furthermore, the vertical integrations and product strategies of the market is increasing the potential for the market players. The players in the market are attempting to create several leaderships that will allow them to secure a more substantial portion of the market. Product differentiation has formed a favorable product differentiation situation that is adding to the market’s progress. The analysis of the market states that it is poised for an increased growth rate in the forthcoming years.

The main competitors in the aseptic sampling market globally are Sartorius Stedim Biotech, Qualitru Sampling Systems, Thermo Fisher Scientific, Danaher Corporation, Flownamics Analytical Instruments, Saint Gobain, GEA Group, Merck KGaA, Keofitt, Gemü Group, W. L. Gore & Associates, Lonza Group, Trace Analytics, and Bürkle GmbH.

Industry Updates:

Feb 2018 CSP Technologies and QualiTru Sampling Systems have created TruDraw, a single-use aseptic sampling system for liquid dairy products. The sampler includes a tamper-evident feature and is a sterilized, sealed container with a sterile needle connected to draw a sample in, shielding against the risk of external adulteration.

Browse More Related Research Reports at:

Americas Blood Glucose Test Strip Market Forecast to 2020 | MRFR

Americas Respiratory Therapeutic Devices Market– Forecast to 2020 | MRFR

Asia Pacific Healthcare Archiving and eDiscovery Market Research Report- Forecast to 2023 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Facial Injectors Market By Type (Dermal Fillers/Injectable Implants, Hyaluronic Acid, Synthetic Fillers, Collagen Fillers, Anti-Aging/Anti-Wrinkle Injections, Botulinum Toxin A, Poly-L-Lactic Acid (PLLA) Microparticles), By Application (Facial Line Correction Treatment, Face-Lift, Lip Treatments), By End-User (Dermatology Clinics & Cosmetic Centers, Hospitals), By Region (Americas, Europe, Asia Pacific and The Middle East & Africa) – Global Forecasts till 2023

Market Research Future (MRFR) has recently published a detailed report stating that the global facial injectors market is set to expand at a significant CAGR of 11.12% during the forecast period from 2018 to 2023 and reach the valuation of USD 14571.47 Mn by the end of the forecast period from USD 7740.16 Mn in the year 2017. Incorporation of advanced technology in the healthcare sector has led to significant improvement in the procedures of cosmetic surgery and facial aesthetic treatment. Consumer preference towards minimally invasive treatments and rise in popularity of facial aesthetic treatments are fueling the demand for facial injectors, which in turn is leading to the noteworthy expansion of the global facial injectors market.

Booming entertainment industry and popularity of celebrity culture are not only affecting the lifestyle of the urban population but also raising the bar higher for beauty standards. Increased research for the development of advanced aesthetic injectors such a soft tissue filler and rise in demand for anti-aging and other beauty treatments in the emerging economies are some other important factors that are propelling the growth of the global facial injectors market. However, side-effects related to the materials used as injectors, serious complications arising during the surgical procedures and availability of black market for facial injectors are likely to act as restraining factors on the growth of the global facial injectors market during the forecast period. Whereas, increasing awareness and acceptance of combination therapies are expected to drive the growth of the global facial injectors market during the assessment period.

Key Players:

Some of the major players profiled by MRFR that are operating in the global facial injectors market are SciVision Biotech Inc, Ipsen Pharma. Merck KGaA, Sanofi, Revance Therapeutics Inc., Sinclair Pharma, Galderma S.A., Suneva Medical Inc., Merz Pharma, Valeant Pharmaceuticals, Allergan, and Integra LifeSciences Corporation.

Detailed Regional Analysis:

The Global facial injectors market has been covered across four major regions such as Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The market in Americas is anticipated to spearhead the global facial injectors market during the forecast period. By the end of 2023, the facial injectors market in the Americas is likely to surpass the valuation of 6339.94, reflecting a healthy CAGR of 10.83%. Rise in popularity of facial aesthetic treatment, increasing disposable income and availability of high-quality treatment with the incorporation of advanced cosmetic technology are primarily contributing to the expansion of the facial injectors market in this region. Meanwhile, the market in the Asia Pacific region is set to record the strongest CAGR of 12.02% during the review period. Booming entertainment industry is influencing the population in the emerging economies to undergo cosmetic surgeries, coupled with increased disposable income, which in turn is resulting in the significant expansion of the facial injectors market in the Asia Pacific region.

Segmental Analysis:

MRFR's report provides an in-depth segmental analysis of the global facial injectors market on the basis of type, application, end-user, and region. Based on type, the facial injectors market has been segmented into dermal fillers/ injectable implants and anti-aging/ anti-wrinkle injections. The dermal fillers/ injectable implants segment accounted for the largest share and is projected to maintain its dominance over the global facial injectors market with the valuation of USD 7934.80, expanding at a CAGR of 11.61%. The dermal fillers/ injectable implants segment has been sub-segmented into hyaluronic acid, synthetic fillers, and collagen fillers. Among these, the hyaluronic acid segment is leading with a significant CAGR of 11.69% in the global facial injectors market. The anti-aging/ anti-wrinkle injections segment has been sub-segmented into botulinum toxin A& poly-L-lactic acid (PLLA) microparticles.

Based on application, the facial injectors market has been segmented into facial line correction treatment, face-lift, lip treatment, and others. The facial line correction treatment segment touted to generate maximum revenue at a CAGR of 10.43%, with the valuation of USD 6382.84 Mn by 2023. Whereas, the face-lift segment is anticipated to project significant expansion at highest CAGR in the global facial injectors market during the assessment period.

Based on end-users, the market has been segmented into dermatology clinics & cosmetic centers, hospitals, and others. The dermatology clinics & cosmetic centers segment currently holds the pole position and is projected to surpass the valuation of USD 6061.35 Mn by 2023, at a CAGR of 10.78% during the forecast period.

Brows More Healthcare Related Research Reports at:

Electrotherapy Market Trends, Size Analysis | Share Value, 2023

Folliculitis Market Size, Growth Analysis | Industry Trends, 2023

Needle Biopsy Market Size, Growth Analysis | Industry Trends, 2023

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com